Fingerprint
Dive into the research topics of 'Developing a dual VEGF/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Developing a dual VEGF/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategy
Noam Tzuri, Ksenia M. Yegodayev, Ofra Novoplansky, Moshe Elkabets, Amir Aharoni, Niv Papo
Research output: Contribution to journal › Article › peer-review